β2 integrin-dependent neutrophil adhesion induced by minimally modified low-density lipoproteins is mainly mediated by F2-isoprostanes

Circulation

Volumn 106, Issue 19, 2002, Pages 2434-2441

  Fontana, Luigi ^a   Giagulli, Cinzia ^a   Cominacini, Luciano ^a   Pasini, Anna Fratta ^a   Minuz, Pietro ^a   Lechi, Alessandro ^a   Sala, Angelo ^a   Laudanna, Carlo ^a  

^a Section of Hematology   (Italy)

Author keywords

Ischemia; Leukocytes; Lipoproteins; Reperfusion

Indexed keywords

BETA2 INTEGRIN; CELL RECEPTOR; FIBRINOGEN; ISOPROSTANE; ISOPROSTANE DERIVATIVE; ISOPROSTANE RECEPTOR; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROSTAGLANDIN F2; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; CD18 ANTIGEN; HYDRAZINE DERIVATIVE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PERTUSSIS TOXIN; THROMBOXANE RECEPTOR;

ARTICLE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ADHERENCE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; OXIDATION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; CELL ADHESION; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; THROMBOCYTE; ULTRAVIOLET RADIATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANTIGENS, CD18; BLOOD PLATELETS; CELL ADHESION; F2-ISOPROSTANES; FIBRINOGEN; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; HYDRAZINES; INTERCELLULAR ADHESION MOLECULE-1; LIPOPROTEINS, LDL; NEUTROPHILS; PERTUSSIS TOXIN; RECEPTORS, THROMBOXANE; SIGNAL TRANSDUCTION; ULTRAVIOLET RAYS;

EID: 0037027298     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000037223.92135.38     Document Type: Article

References (33)

1. Glass CK, Witztum JL. Atherosclerosis: The road ahead. Cell. 2001;104: 503-516.
2. Pratico D, Iuliano L, Mauriello A, et al. Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Invest. 1997;100: 2028-2034.
3. Lynch SM, Morrow JD, Roberts LJ II, et al. Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest. 1994:93: 998-1004.
4. Lawson JA, Rokach J, FitzGerald GA. Isoprostanes: Formation, analysis and use as indices of lipid peroxidation in vivo. J Biol Chem. 1999;274: 24441-24444.
5. Delanty N, Reilly MP, Pratico D, et al. 8-epi PGF2 α generation during coronary reperfusion: A potential quantitative marker of oxidant stress in vivo. Circulations. 1997;95:2492-2499.
6. Iuliano L, Praticò D, Greco C, et al. Angioplasty increases coronary sinus F2-isoprostanes formation: Evidence for in vivo oxidative stress during PTCA. J Am Coll Cardiol. 200137:76-80.
7. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: Smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198-1203.
8. Davi G, Ciabattoni G, Consoli A, et al. In vivo formation of 8-iso-prostaglandin f2α and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation. Circulation. 1999;99:224-229.
9. Reilly MP, Pratico D, Delanty N, et al. Increased formation of distinct F2 isoprostanes in hypercholesterolemia. Circulation. 1998;98:2822-2828.
10. Voutilainen S, Morrow JD, Roberts LJ II, et al. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol. 1999;19:1263-1266.
11. Audoly LP, Rocca B, Fabre JE, et al. Cardiovascular responses to the isoprostanes iPF(2α)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo. Circulation. 2000;101:2833-2840.
12. Minuz P, Andrioli G, Degan M, et al. The F2-isoprostane 8-epiprostaglandin F2alpha increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vasc Biol. 1998; 18:1248-1256.
13. 2 integrin-mediated rapid adhesion of human polymorphonuclear neutrophils: A link between oxidative stress and ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol. 2001;21:55-60.
14. Roque M, Fallon JT, Badimon JJ, et al. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol. 2000;20:335-342.
15. Simon DI, Chen Z, Seifert P, et al. Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty. J Clin Invest. 2000;105:293-300.
16. Hedman H, Branden H, Lundgren E. Physical separation of ICAM-1 binding cells. J Immunol Methods. 1992;146:203-211.
17. Havel RJ, Eder MA, Bragdon JM. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
18. Cominacini L, Garbin U, Davoli A, et al. A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. J Lipid Res. 1991;32:349-358.
19. Cominacini L, Garbin U, De Santis A, et al. Mechanisms involved in the in vitro modification of low density lipoprotein by human umbilical vein endothelial cells and copper ions. J Lipid Mediat Cell Signal. 1996;13: 19-33.
20. 2α excretion in man. J Pharmacol Exp Ther. 1995;275:94-100.
21. Boyum A. Isolation of mononuclear cells and granulocytes from human blood: Isolation of monocular cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77-89.
22. Laudanna C, Campbell JJ, Butcher EC. Role of Rho in chemoattractant-activated leukocyte adhesion through integrins. Science. 1996;271: 981-983.
23. Laudanna C, Mochly-Rosen D, Liron T, et al. Evidence of zeta protein kinase C involvement in polymorphonuclear neutrophil integrindependent adhesion and chemotaxis. J Biol Chem. 1998;273:30306-30315.
24. Arnould T, Michiels C, Remacle J. Increased PMN adherence on endothelial cells after hypoxia: Involvement of PAF, CD18/CD11b, and ICAM-1. Am J Physiol. 1993;264:C1102-C1110.
25. Inoue T, Sakai Y, Hoshi K. et al. Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting balloon angioplasty, Circulation. 1998;97: 2511-2518.
26. Fishell TA, Derby G, Tse TM, et al. Coronary artery vasoconstriction routinely occurs after percutaneous transiuminal coronary angioplasty: A quantitative arteriographic analysis, Circulation. 1988;78: 1323-1334.
27. Thornton MA, Gruentzig AR, Hollman J, et al. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: A randomized study. Circulation. 1984;69:721-727.
28. Schwartz L, Bourassa MG, Lesperance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med. 1998;318:1714-1719.
29. Pratico D, Tangirala RK, Rader DJ, et al. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med. 1998;4:1189-1192.
30. Lafont AM, Chai YC, Cornhill JF, et al. Effect of α-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. J Clin Invest. 1995;95:1018-1025.
31. Tardif JC, Cote G, Lesperance J, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty: Multivitamins and Probucol Study Group. N Engl J Med. 1997;337:365-372.
32. Skalen K, Gustafsson M, Rydberg EK, et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002;417: 750-754.
33. Buffon A, Biasucci LM, Liuzzo G, et al. Widespread coronary inflammation in unstable angina. N Engl J Med. 2002;347:5-12.